[Evaluation of trimethoprim-sulfamethoxazole combination (Bactrim) as a therapeutic agent in pediatrics].
D000293:Adolescent; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D004361:Drug Tolerance; D005069:Evaluation Studies as Topic; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Therapeutische Wertigkeit des Kombinationspräparates Trimethoprim-Sulfamethoxazol (Bactrim) in der Kinderheilkunde.